Importantly, JUN emerges as a key factor spanning all analytical pillars—being over-expressed in AD, downregulated following EVOO consumption, associated with EVOO’s bioactive compounds, and part of the NRF2 interaction network. The gene discussed is NFE2L2; the disease is Alzheimer disease.